Background: Due to Multiple Sclerosis (MS) being one of the most common neurological disorders in young adults, it is essential that as future health care professionals, we are educated on different types of alternative treatments. Recent research has shown that individuals with MS are open to considering medical marijuana as a treatment for common symptoms associated with this disease. This population, among others, would benefit from continued research on this topic to further prove its effectiveness for symptom relief. Purpose: The purpose of this study was to systematically review the existing literature regarding the effectiveness of medical cannabis in treating common symptoms experienced by individuals with MS. Methods: A literature ...
Summary The American Academy of Neurology published an evidence-based systematic review of randomize...
Abstract—To estimate the patterns and prevalence of cannabis use among patients with multiple sclero...
A large proportion of patients with multiple sclerosis (MS) have spasticity, which has a marked impa...
Background: Due to Multiple Sclerosis (MS) being one of the most common neurological disorders in yo...
Multiple sclerosis (MS) is a neurodegenerative disease that affects over 2 million people worldwide....
ObjectiveTo determine the efficacy of medical marijuana in several neurologic conditions.MethodsWe p...
Purpose of review: Pharmaceutical cannabinoids such as nabiximols, nabilone and dronabinol, and plan...
OBJECTIVE: To determine the efficacy of medical marijuana in several neurologic conditions. METHODS:...
Multiple sclerosis (MS) is known as an autoimmune disease that damages the neurons in the central ne...
Background: Spasticity and chronic neuropathic pain are common and serious symptoms in people with m...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not cannabis is eff...
Despite current therapeutic strategies for immunomodulation and relief of symptoms in multiple scler...
IMPORTANCE: Cannabinoids have antispastic and analgesic effects; however, their role in the treatmen...
Introduction: Research suggests that cannabis helps relieve multiple sclerosis (MS)-associated pain ...
The objective was to determine whether a cannabis-based medicinal extract (CBME) benefits a range of...
Summary The American Academy of Neurology published an evidence-based systematic review of randomize...
Abstract—To estimate the patterns and prevalence of cannabis use among patients with multiple sclero...
A large proportion of patients with multiple sclerosis (MS) have spasticity, which has a marked impa...
Background: Due to Multiple Sclerosis (MS) being one of the most common neurological disorders in yo...
Multiple sclerosis (MS) is a neurodegenerative disease that affects over 2 million people worldwide....
ObjectiveTo determine the efficacy of medical marijuana in several neurologic conditions.MethodsWe p...
Purpose of review: Pharmaceutical cannabinoids such as nabiximols, nabilone and dronabinol, and plan...
OBJECTIVE: To determine the efficacy of medical marijuana in several neurologic conditions. METHODS:...
Multiple sclerosis (MS) is known as an autoimmune disease that damages the neurons in the central ne...
Background: Spasticity and chronic neuropathic pain are common and serious symptoms in people with m...
OBJECTIVE: The objective of this selective EBM review is to determine whether or not cannabis is eff...
Despite current therapeutic strategies for immunomodulation and relief of symptoms in multiple scler...
IMPORTANCE: Cannabinoids have antispastic and analgesic effects; however, their role in the treatmen...
Introduction: Research suggests that cannabis helps relieve multiple sclerosis (MS)-associated pain ...
The objective was to determine whether a cannabis-based medicinal extract (CBME) benefits a range of...
Summary The American Academy of Neurology published an evidence-based systematic review of randomize...
Abstract—To estimate the patterns and prevalence of cannabis use among patients with multiple sclero...
A large proportion of patients with multiple sclerosis (MS) have spasticity, which has a marked impa...